cover image - Study Guide for Lilley's Pharmacology for Canadian Health Care Practice - Elsevier eBook on VitalSource, 4th Edition
ISBN: 9780323694605
Copyright: 2021
Publication Date: 09-23-2020
Page Count: 256
Imprint: Mosby Canada
List Price: $32.99

Study Guide for Lilley's Pharmacology for Canadian Health Care Practice - Elsevier eBook on VitalSource, 4th Edition

by Kara Sealock, RN, BN, MEd, EdD and Cydnee Seneviratne, RN, BScN, MN, PhD

Elsevier eBook on VitalSource

cover image - Study Guide for Lilley's Pharmacology for Canadian Health Care Practice - Elsevier eBook on VitalSource, 4th Edition
ISBN: 9780323694605
Copyright: 2021
Publication Date: 09-23-2020
Page Count: 256
Imprint: Mosby Canada
List Price: $32.99
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Elsevier Sales Rep.
An Access Code
Important note
You are viewing the faculty version.
Students requesting access will be reported.

Help ensure your students’ mastery of need-to-know Canadian pharmacology nursing principles with the Study Guide for Lilley’s Pharmacology for Canadian Health Care Practice, 4th Edition. Designed to accompany the Lilley’s Pharmacology for Canadian Health Care Practice 4th Edition textbook, this dynamic study guide helps students better understand, retain, and apply the information and concepts from each chapter of the text. Worksheets for each chapter include multiple-choice questions, critical thinking and application questions, case studies, plus a wealth of other learning activities to fully prepare students for their credentialing exams.

Newer Edition Available

    • NEW! Thoroughly updated content reflects the organization and updated information housed in the fourth edition of Lilley’s Pharmacology for Canadian Health Care Practice.
    • NEW! Thoroughly updated content reflects the organization and updated information housed in the fourth edition of Lilley’s Pharmacology for Canadian Health Care Practice.
    • Chapter review and examination preparation is included in each chapter worksheet and contains a number of application-based NCLEX® style practice questions, including at least one alternate-item question per chapter.
    • Focus on prioritization features at least one prioritization exercise in which students must evaluate a clinical scenario and answer the question: "What is the nurse’s best action?" These exercises provide students with practice in identifying the most important, need-to-know nursing actions.
    • Overview of Dosage Calculations section features explanations of key drug calculations concepts, sample drug labels, practice problems, and a practice quiz.
    • UNIQUE! Cartoon-illustrated student study tips expands upon the study skills tips that are included on the accompanying Evolve site.
    • Answers for all exercises are provided at the back of the book to facilitate self-study.
    • Chapter-by-chapter worksheets are divided into three main sections: chapter review and examination preparation including multiple-choice and matching questions; critical thinking and application questions with some chapters including a critical thinking crossword puzzle; and case studies.
    • Question variety includes fill-in-the-blank, multiple choice, labelling and ordering, matching, and short answer.
  • Part One: Pharmacology Basics
    1. Nursing Practice in Canada and Drug Therapy
    2. Pharmacological Principles
    3. Legal and Ethical Considerations
    4. Patient-Focused Considerations
    5. Gene Therapy and Pharmacogenomics
    6. Medication Errors: Preventing and Responding
    7. Patient Education and Drug Therapy
    8. Over-the-Counter Drugs and Natural Health Products
    9. Vitamins and Minerals
    10. Principles of Drug Administration

    Part Two: Drugs Affecting the Central Nervous System
    11. Analgesic Drugs
    12. General and Local Anaesthetics
    13. Central Nervous System Depressants and Muscle Relaxants
    14. Central Nervous System Stimulants and Related Drugs
    15. Antiepileptic Drugs
    16. Antiparkinsonian Drugs
    17. Psychotherapeutic Drugs
    18. Substance Misuse

    Part Three: Drugs Affecting the Autonomic Nervous System
    19. Adrenergic Drugs
    20. Adrenergic-Blocking Drugs
    21. Cholinergic Drugs
    22. Cholinergic-Blocking Drugs

    Part Four: Drugs Affecting the Cardiovascular and Renal Systems
    23. Antihypertensive Drugs
    24. Antianginal Drugs
    25. Heart Failure Drugs
    26. Antidysrhythmic Drugs
    27. Coagulation Modifier Drugs
    28. Antilipemic Drugs
    29. Diuretic Drugs
    30. Fluids and Electrolytes

    Part Five: Drugs Affecting the Endocrine System
    31. Pituitary Drugs
    32. Thyroid and Antithyroid Drugs
    33. Antidiabetic Drugs
    34. Adrenal Drugs
    35. Women's Health Drugs
    36. Men's Health Drugs

    Part Six: Drugs Affecting the Respiratory System
    37. Antihistamines, Decongestants, Antitussives, and Expectorants
    38. Respiratory Drugs

    Part Seven: Drugs Affecting the Gastrointestinal System and Nutrition
    39. Acid-Controlling Drugs
    40. Antidiarrheal Drugs and Laxatives
    41. Antiemetic and Antinausea Drugs
    42. Nutritional Supplements

    Part Eight: Anti-infective and Anti-inflammatory Drugs
    43. Antibiotics Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines
    44. Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other Drugs
    45. Antiviral Drugs
    46. Antitubercular Drugs
    47. Antifungal Drugs
    48. Antimalarial, Antiprotozoal, and Anthelmintic Drugs
    49. Anti-inflammatory and Antigout Drugs

    Part Nine: Immune and Biological Modifiers and Chemotherapeutic Drugs
    50. Immunosuppressant Drugs
    51. Immunizing Drugs and Pandemic Preparedness
    52. Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle - Specific Drugs
    53. Antineoplastic Drugs Part 2: Cell Cycle - Nonspecific and Miscellaneous Drugs
    54. Biological Response - Modifying Drugs and Antirheumatic Drugs

    Part Ten: Miscellaneous Therapeutics: Hematological, Dermatological, Ophthalmic, and Otic Drugs
    55. Anemia Drugs
    56. Dermatological Drugs
    57. Ophthalmic Drugs
    58. Otic Drugs

  • Kara Sealock, RN, BN, MEd, EdD, Professor, Faculty of Nursing, University of Calgary, Calgary, Alberta, Canada; Chief Editor, The Canadian Journal of Critical Care Nursing and Cydnee Seneviratne, RN, BScN, MN, PhD, University of Calgary, Faculty of Nursing
    Calgary, Alberta
    • Ways of Reading
      • The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
      • This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
      • No information about nonvisual reading is available
    • Conformance
      • No information is available
    • Navigation
      • Table of contents to all chapters of the text via links
      • Page list to go to pages from the print source version
    • Rich Content
      • No information is available
    • Hazards
      • No information is available
    • Product Content
      • No information is available
    • Legal Considerations
      • No information is available
    • Additional Accessibility Information
      • Page breaks included from the original print source
      • For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
      • E-publication includes basic navigation (usually less detailed than TOC-based navigation)
      • Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
      • All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
      • The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
Most review copies are eBooks – how fast!
A review copy request is most likely to be fulfilled as an eBook on VitalSource rather than a print product, unless no eBook is available. eBooks become available in as little as a few hours. Print products will take between 7 and 10 days to arrive. To request a print copy, please contact us through the Evolve Support Center for further assistance or contact your Elsevier Sales Rep.
An Access Code
Important note
You are viewing the faculty version.
Students requesting access will be reported.